Filing Flows › Comparisons › TNYA vs CRBU
Tenaya Therapeutics vs Caribou Biosciences: TNYA and CRBU compared
Tenaya Therapeutics is the larger company: $1.7M of revenue in its latest quarter (Q3 2026) against $1.6M for Caribou Biosciences (Q3 2026).
Where the money goes: TNYA and CRBU
Tenaya Therapeutics (TNYA) · Q3 2026
Tenaya Therapeutics, Q3 2026: revenue $1.7M, net loss $18.9M, operating cash flow −$17.7M. The chart follows the revenue to costs, profit and cash.
Caribou Biosciences (CRBU) · Q3 2026
Caribou Biosciences, Q3 2026: revenue $1.6M (-27% year over year), net loss $26.6M, operating cash flow −$22.5M. The chart follows the revenue to costs, profit and cash.
| Tenaya Therapeutics (TNYA) | Caribou Biosciences (CRBU) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.7M | $1.6M |
| Revenue growth, Y/Y | — | -27% |
| Operating margin | n/m | n/m |
| Net earnings | −$18.9M | −$26.6M |
| Operating cash flow | −$17.7M | −$22.5M |
Questions
Which is bigger, Tenaya Therapeutics or Caribou Biosciences?
Tenaya Therapeutics is the larger company: $1.7M of revenue in its latest quarter (Q3 2026) against $1.6M for Caribou Biosciences (Q3 2026).
More: Tenaya Therapeutics earnings · how Tenaya Therapeutics makes money · Caribou Biosciences earnings · how Caribou Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.